Modeled elimination speed is a PK→PD construct describing how clearance geometry, elimination rate, concentration-dependent clearance, distribution loading, distribution geometry, redistribution timing, absorption rate, absorption timing, solubility, and gastric emptying shape declining-phase geometry for sildenafil and avanafil. “Elimination speed” refers strictly to modeled PK→PD behavior, not real-world elimination. Clearance geometry determines removal dynamics, elimination rate determines modeled decline steepness, and concentration-dependent clearance introduces curvature. Distribution loading determines early central availability, distribution geometry determines compartmental spread, and redistribution timing determines temporal alignment between compartments. Absorption rate and timing shape the rising-phase input, solubility determines dissolution-driven availability, and gastric emptying determines input arrival. These PK parameters generate concentration-time trajectories. PD interpretation then determines modeled onset and peak geometry: threshold placement defines the onset boundary, binding sensitivity transforms concentration differences, coupling geometry shapes downstream transitions, and PD noise bands add interpretation variability. Link to the speed overview.
Modeled elimination-speed comparison describes how parameterized decline trajectories differ between sildenafil and avanafil. Faster modeled clearance accelerates decline, reducing modeled exposure persistence and shifting half-life geometry. Slower modeled clearance prolongs modeled persistence, broadening the declining-phase region. Concentration-dependent clearance can reshape curvature, making decline steeper at higher concentrations and shallower at lower ones. Distribution loading determines early central-compartment concentration, while distribution geometry determines how rapidly absorbed material spreads across compartments. Redistribution timing determines alignment between central and peripheral decline. Absorption rate steepens the rising phase, absorption timing shifts the rising phase, solubility determines dissolution-driven availability, and gastric emptying variability shifts input arrival. These mechanisms interact: faster modeled clearance may be offset by broader distribution geometry, while earlier absorption timing may be offset by slower elimination. Under elimination modeling, PK geometry supplies the input curve that PD parameters transform. Link to metabolism speed.
PD geometry shapes elimination-speed comparison by transforming the modeled PK trajectory into threshold, binding, and coupling coordinates. Threshold placement determines where the PK curve intersects the modeled onset coordinate. Binding sensitivity determines how concentration differences are transformed into binding differences; higher modeled sensitivity can expand separation, while lower sensitivity can compress it. Coupling geometry determines how binding is mapped into downstream PD signals; shallow slopes broaden transitions, while steep slopes compress them. PD noise bands widen or narrow interpretation regions. Because sildenafil and avanafil can be represented by differing parameter sets for clearance geometry, elimination rate, concentration-dependent clearance, distribution loading, distribution geometry, absorption rate, solubility, gastric emptying, and Tmax/Cmax geometry, the resulting PK→PD mapping can expand or compress modeled elimination-speed differences. The same mapping can shift modeled onset-speed and peak-speed coordinates without implying clinical outcomes. Link to peak time.
Clearance geometry, elimination rate, and concentration-dependent clearance define the mathematical decline operator applied to the modeled concentration trajectory. Clearance geometry controls how removal is represented across time, while elimination rate controls the local steepness of decline. Concentration-dependent clearance introduces state-dependent curvature, so the same trajectory can decline with different slopes across concentration ranges. Distribution loading establishes the initial central amount available for redistribution and removal. Distribution geometry determines how material occupies modeled compartments, and redistribution timing controls when peripheral exchange contributes to the central trajectory. Absorption rate and absorption timing define the preceding input function; solubility shapes dissolution-driven availability, and gastric emptying controls modeled arrival timing. First-pass metabolism and bioavailability scale the systemic input entering the model. Tmax geometry and Cmax geometry summarize where the rising and peak regions occur before the declining phase begins. Together, these parameters create the PK trajectory used for sildenafil–avanafil elimination-speed comparison. Link to metabolism rate speed.
PK variability produces families of modeled elimination-speed trajectories rather than a single fixed decline curve. Changes in clearance geometry can alter the steepness and curvature of the terminal region, while variation in elimination rate shifts the mathematical decline constant. Concentration-dependent clearance can make these differences state dependent. Distribution loading and distribution geometry alter how much modeled material remains in the central compartment and how exchange between compartments contributes to later concentrations. Redistribution timing can therefore shift the apparent transition between distribution-dominated and elimination-dominated regions. Upstream variability also propagates forward: absorption rate, absorption timing, solubility, gastric emptying, first-pass metabolism, and bioavailability alter the input function, while Tmax and Cmax geometry change the starting conditions for the declining phase. In a sildenafil-versus-avanafil model, these parameter sets can generate overlapping, separated, or crossing elimination-speed windows. The resulting spread is a property of the model parameter space, not a statement about real-world elimination behavior. Link to distribution speed.
| PK Domain | Elimination Interaction | Link |
|---|---|---|
| Clearance Geometry | Removal dynamics. | metabolism speed |
| Concentration-Dependent Clearance | Curvature shaping. | metabolism rate speed |
| Distribution Geometry | Compartmental spread. | distribution speed |
Threshold placement determines how a declining PK trajectory is converted into a modeled elimination-speed timing coordinate. A higher modeled threshold intersects the concentration curve earlier during decline, whereas a lower threshold intersects it later, without changing the underlying PK trajectory. This means two identical clearance profiles can produce different modeled timing coordinates solely because their PD threshold positions differ. Binding sensitivity then determines how concentration changes around that coordinate translate into modeled interaction changes. Coupling geometry maps binding changes into downstream PD signal transitions, and its slope can compress or broaden the corresponding timing region. PD noise bands add an uncertainty envelope around these modeled coordinates, allowing parameter perturbations to appear as wider or narrower interpretation bands. Thus, threshold placement, binding sensitivity, coupling geometry, and noise bands act after the PK trajectory has been generated. The resulting output is a PK→PD elimination geometry, with onset-speed and peak-speed coordinates defined mathematically rather than clinically. Link to pd speed.
Binding sensitivity, coupling geometry, and PD noise bands can amplify, compress, or broaden differences that originate in PK elimination geometry. If binding sensitivity is steep around a modeled concentration region, small PK separation can produce larger modeled interaction separation. If sensitivity is shallow, the same concentration difference can map to a smaller PD difference. Coupling geometry adds another transformation: a steep downstream relationship compresses concentration-to-effect transitions, whereas a shallow relationship spreads them across a wider concentration interval. Noise bands then surround the transformed trajectory and can overlap otherwise separated modeled regions. PK speed and PD speed therefore describe different stages of the same mapping: PK parameters generate concentration trajectories, while PD parameters transform those trajectories into modeled timing and peak coordinates. Clearance geometry, half-life geometry, distribution loading, redistribution timing, Tmax geometry, and Cmax geometry can all influence the source trajectory before this transformation. The final separation remains a mathematical model property, not a real-world effectiveness or outcome claim. Link to pk speed.
| PD Domain | Elimination Effect | Link |
|---|---|---|
| Threshold Placement | Earlier/later onset. | onset time |
| Binding Sensitivity | Amplification/compression. | onset variability comparison |
| Coupling Geometry | Slope-driven shaping. | peak variability comparison |
Modeled elimination-speed differences arise from the parameterized relationship between systemic concentration and its decline over time. Clearance geometry specifies how removal is represented, while elimination rate controls decline steepness. Concentration-dependent clearance can add curvature when removal varies with modeled concentration. Distribution loading, distribution geometry, and redistribution timing influence how material is represented across compartments during the declining phase. Upstream absorption parameters also matter because absorption rate, absorption timing, solubility, and gastric emptying determine the input function that establishes the trajectory’s starting conditions. First-pass metabolism and bioavailability scale that modeled systemic input. Half-life geometry summarizes a selected decline region rather than asserting a real-world half-life. Tmax and Cmax geometry define the peak-region coordinates that precede decline. Sildenafil and avanafil can therefore show different modeled elimination-speed trajectories when their parameter sets differ.
The main PK mechanisms are clearance geometry, elimination rate, concentration-dependent clearance, distribution loading, distribution geometry, redistribution timing, and the upstream absorption system. Clearance geometry determines the mathematical removal pattern, while elimination rate controls the rate of modeled concentration decline. Concentration-dependent clearance can make the decline nonlinear. Distribution loading and distribution geometry determine how modeled material is partitioned across compartments, and redistribution timing affects when compartment exchange contributes to the central trajectory. Absorption rate, absorption timing, solubility, and gastric emptying define the systemic input that precedes elimination. First-pass metabolism and bioavailability scale that input. Half-life geometry describes a selected decline interval within the model, while Tmax and Cmax geometry establish the peak-region coordinates from which decline begins. These mechanisms can interact, so elimination-speed differences cannot be represented by a single parameter alone. All interpretations remain mathematical PK constructs without real-world pharmacologic or clinical meaning.
PD mechanisms shape elimination geometry by transforming concentration trajectories into modeled interaction coordinates. Threshold placement establishes the concentration boundary used to mark a timing transition. Moving that threshold changes where the trajectory intersects the boundary without altering the underlying PK curve. Binding sensitivity controls how concentration separation is translated into modeled binding separation, potentially expanding or compressing differences. Coupling geometry determines how binding coordinates map into downstream PD signals, with slope controlling transition width. PD noise bands surround the transformed trajectory and represent modeled interpretation variability. These parameters can change the apparent separation between sildenafil and avanafil in modeled onset-speed or peak-speed coordinates even when their underlying PK trajectories are unchanged. Conversely, different PK trajectories can converge after PD transformation if the coupling is sufficiently compressive. The result is a mathematical PK→PD geometry in which elimination, onset, and peak coordinates are linked through explicit model parameters rather than clinical observations or outcome measures.
Sildenafil and avanafil differ in modeled elimination geometry when their parameterized clearance, distribution, absorption, metabolism, or bioavailability inputs differ. Clearance geometry and elimination rate directly shape the declining trajectory, while concentration-dependent clearance can alter its curvature. Distribution loading, distribution geometry, and redistribution timing influence how the central trajectory is assembled across compartments. Upstream absorption rate, absorption timing, solubility, and gastric emptying affect the input function that precedes the decline. First-pass metabolism and bioavailability scale the systemic input, while Tmax and Cmax geometry establish the peak-region starting coordinates. A half-life geometry parameter then describes a selected mathematical decline interval. PD threshold placement, binding sensitivity, coupling geometry, and noise bands transform these PK differences into modeled timing coordinates. Therefore, a difference between the two modeled profiles can arise from one parameter or from interactions among several parameters. The comparison remains a mechanistic model of trajectory geometry, not an interpretation of real-world elimination or clinical outcomes.
PK→PD mapping explains elimination-speed differences by separating trajectory generation from trajectory interpretation. PK parameters first generate a concentration-time curve: absorption determines input, distribution determines compartmental movement, metabolism and clearance determine removal, and half-life geometry summarizes a selected decline segment. Tmax and Cmax geometry locate the peak region before the declining phase. PD parameters then transform concentration into modeled interaction coordinates. Threshold placement selects a boundary, binding sensitivity determines how concentration differences are translated into binding differences, and coupling geometry maps binding into downstream signal changes. Noise bands add a modeled envelope around those transformed coordinates. Consequently, two PK curves with similar decline slopes can produce different modeled timing coordinates if their PD parameters differ, while different PK curves can appear closer after a compressive PD transformation. This framework connects elimination speed with onset-speed and peak-speed geometry while keeping every term within the mathematical PK→PD model. It does not establish real-world elimination, treatment response, or patient outcomes.